Paper40940935
Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers.
Krawczyk E. Cancers (Basel), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers. Papers, record 40940935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940935
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38541741 | Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38541741 | PubMed |
| 2 | 11413492 | Hayflick, his limit, and cellular ageing. | Nat Rev Mol Cell Biol | 2000 | https://conductscience.org/library/papers/11413492 | PubMed |
| 3 | 36477880 | Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods. | J Med Virol | 2023 | https://conductscience.org/library/papers/36477880 | PubMed |
| 4 | 29721720 | Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment. | Clin Transl Med | 2018 | https://conductscience.org/library/papers/29721720 | PubMed |
| 5 | 29973296 | Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis. | Stem Cell Res Ther | 2018 | https://conductscience.org/library/papers/29973296 | PubMed |
| 6 | 36146860 | The First Human Vulvar Intraepithelial Neoplasia Cell Line with Naturally Infected Episomal HPV18 Genome. | Viruses | 2022 | https://conductscience.org/library/papers/36146860 | PubMed |
| 7 | 31623313 | CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31623313 | PubMed |
| 8 | 35305968 | Analysis of the diagnosis of Japanese patients with primary ciliary dyskinesia using a conditional reprogramming culture. | Respir Investig | 2022 | https://conductscience.org/library/papers/35305968 | PubMed |
| 9 | 29970881 | Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29970881 | PubMed |
| 10 | 14519650 | Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/14519650 | PubMed |
| 11 | 26283301 | Developing in vitro models of human ductal carcinoma in situ from primary tissue explants. | Breast Cancer Res Treat | 2015 | https://conductscience.org/library/papers/26283301 | PubMed |
| 12 | 32064165 | Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitors. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32064165 | PubMed |
| 13 | 26536825 | Precision medicine for cancer with next-generation functional diagnostics. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26536825 | PubMed |
| 14 | 31164413 | The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells. | Mol Cancer Res | 2019 | https://conductscience.org/library/papers/31164413 | PubMed |
| 15 | 37376685 | Conditional Cell Reprogramming and Air-Liquid Interface Modeling Life Cycle of Oncogenic Viruses (HPV and EBV) in Epithelial Cells and Virus-Associated Human Carcinomas. | Viruses | 2023 | https://conductscience.org/library/papers/37376685 | PubMed |
| 16 | 30420612 | Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer. | Br J Cancer | 2018 | https://conductscience.org/library/papers/30420612 | PubMed |
| 17 | 29212548 | Generation of stable PDX derived cell lines using conditional reprogramming. | Mol Cancer | 2017 | https://conductscience.org/library/papers/29212548 | PubMed |
| 18 | 25714835 | Multifactorial analysis of conditional reprogramming of human keratinocytes. | PLoS One | 2015 | https://conductscience.org/library/papers/25714835 | PubMed |
| 19 | 22460905 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | https://conductscience.org/library/papers/22460905 | PubMed |
| 20 | 35084050 | Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. | Prostate | 2022 | https://conductscience.org/library/papers/35084050 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40940935
GET https://conductscience.org/api/papers/v1/40940935/references?page=2